# Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

> **NCT04134169** · — · UNKNOWN · sponsor: **Kang Stem Biotech Co., Ltd.** · enrollment: 28 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** Not applicable(observational study)

## Key facts

- **NCT ID:** NCT04134169
- **Lead sponsor:** Kang Stem Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-02
- **Primary completion:** 2025-08-11
- **Final completion:** 2026-04-11
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2022-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04134169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04134169, "Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04134169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*